TITLE

A unified framework for the evaluation of surrogate endpoints in mental-health clinical trials

AUTHOR(S)
Molenberghs, Geert; Burzykowski, Tomasz; Alonso, Ariel; Assam, Pryseley; Tilahun, Abel; Buyse, Marc
PUB. DATE
June 2010
SOURCE
Statistical Methods in Medical Research;Jun2010, Vol. 19 Issue 3, p205
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
For a number of reasons, surrogate endpoints are considered instead of the so-called true endpoint in clinical studies, especially when such endpoints can be measured earlier, and/or with less burden for patient and experimenter. Surrogate endpoints may occur more frequently than their standard counterparts. For these reasons, it is not surprising that the use of surrogate endpoints in clinical practice is increasing. Building on the seminal work of Prentice and Freedman et al., Buyse et al. framed the evaluation exercise within a meta-analytic setting, in an effort to overcome difficulties that necessarily surround evaluation efforts based on a single trial. In this article, we review the meta-analytic approach for continuous outcomes, discuss extensions to non-normal and longitudinal settings, as well as proposals to unify the somewhat disparate collection of validation measures currently on the market. Implications for design and for predicting the effect of treatment in a new trial, based on the surrogate, are discussed. A case study in schizophrenia is analysed.
ACCESSION #
51995935

 

Related Articles

  • Evaluation of clinical effectiveness and direct drug costs of different antipsychotics in inpatient settings. Faris, Gavrankapetanovic; Jasmina, Krehic; Lilijana, Oruc // HealthMed;2011, Vol. 5 Issue 4, p857 

    The treatment of schizophrenia is a complex issue. Considering the costs of disease this is one of the most expensive psychiatric disorders. To evaluate clinical effectiveness and direct drug costs of different antipsychotics after one month therapy in patients with acute psychotic episodes of...

  • Mediation and moderation of treatment effects in randomised controlled trials of complex interventions. Emsley, Richard; Dunn, Graham; White, Ian R. // Statistical Methods in Medical Research;Jun2010, Vol. 19 Issue 3, p237 

    Complex intervention trials should be able to answer both pragmatic and explanatory questions in order to test the theories motivating the intervention and help understand the underlying nature of the clinical problem being tested. Key to this is the estimation of direct effects of treatment and...

  • Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials. Stauffer, Virginia; Ascher-Svanum, Haya; Lin Liu; Ball, Tamara; Conley, Robert // BMC Psychiatry;2009, Vol. 9, Special section p1 

    Background: How long an antipsychotic is effective in maintaining response is important in choosing the correct treatment for people with schizophrenia. This post-hoc analysis describes maintenance of response over 24 or 28 weeks in people treated for schizophrenia with olanzapine, risperidone,...

  • Mental health problems: treatment in schizophrenia. Griffiths, Janet // Dental Nursing;Dec2008, Vol. 4 Issue 12, p684 

    The article outlines the factors that must be taken into account when treating individuals with schizophrenia, a severe emotional disorder. Treating this kind of disease involves a range of pharmacological and psychological treatments that should be accompanied by professional support from...

  • Modelling the Treated Course of Schizophrenia: Development of a Discrete Event Simulation Model. Heeg, Bart M. S.; Buskens, Erik; Knapp, Martin; van Aalst, Gerda; Dries, Pieter J. T.; de Haan, Lieuwe; van Hout, Ben A. // PharmacoEconomics;2005 Supplement, Vol. 23, p17 

    In schizophrenia, modelling techniques may be needed to estimate the long-term costs and effects of new interventions. However, it seems that a simple direct link between symptoms and costs does not exist. Decisions about whether a patient will be hospitalized or admitted to a different...

  • POLICY MAKING'S UNINTENDED CONSEQUENCES. Oss, Monica E. // Behavioral Healthcare;Mar2006, Vol. 26 Issue 3, p56 

    Comments on the proposed preauthorization requirements for newer antipsychopathic access to people who suffer from schizophrenia in the Medicaid program in Iowa. Disadvantages of the proposal; Other options that can be considered in managing the cost of the treatment of schizophrenia; Planning...

  • Therapist variation within randomised trials of psychotherapy: implications for precision, internal and external validity. Walwyn, Rebecca; Roberts, Chris // Statistical Methods in Medical Research;Jun2010, Vol. 19 Issue 3, p291 

    Nesting of patients within therapists in psychotherapy trials creates an additional level within the design. The multilevel nature of this design has implications for the precision, internal and external validity of estimates of the treatment effect. Prior to or during a trial, psychotherapies...

  • Quetiapine in the Long-Term Treatment of Schizophrenia.  // Child & Adolescent Psychopharmacology News;Aug2004, Vol. 9 Issue 5, p10 

    The article examines the long-term potency and safety of quetiapine in patients with schizophrenia using joint data from the open-label extension (OLE) of four Phase IIIa trials. The eligible patients that were selected for this study were from Europe, Canada and South Africa, and OLE phases...

  • Factors that influenced county system leaders to implement an evidence-based program: a baseline survey within a randomized controlled trial. Wei Wang; Saldana, Lisa; Brown, C. Hendricks; Chamberlain, Patricia // Implementation Science;2010, Vol. 5, p72 

    Background: Despite the burgeoning number of well-validated interventions that have been shown in randomized trials to produce superior outcomes compared to usual services, it is estimated that only 10% of public systems deliver evidence-based mental health services. In California, for example,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics